Delivery Order SPE2DB22D2009-SPE2DB25FL8XF

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,338.94, is for the procurement of Chloraseptic Max 15-10 mg lozenges. The contract is a firm fixed-price delivery order, with a period of performance through January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,076.39 firm fixed-price delivery order is for the supply of Chloraseptic Max 15-10 mg lozenge products, with a performance period ending on May 14, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,111.64, is for the supply of 4,567,926,337 units of Chloraseptic sore throat lozenges. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,156.09 firm fixed-price delivery order is for the supply of Chloraseptic Max 15-10 mg lozenges to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,533.11, is for the delivery of Chloraseptic Sore 18s, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period extending through May 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This contract award, valued at $2,241.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is a firm fixed price delivery order for the supply of pharmaceutical products, specifically Chloraseptic Max 15-10 mg lozenges, to support military treatment programs and facilities. The contract has an ultimate completion date of April 11, 2024. This delivery...
This federal contract award is a delivery order with a firm fixed price valued at $1,457.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566405605 - CHLORASEPTIC MAX 15-10 MG LOZ 15S, with a period of performance through November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,229.94 Firm Fixed Price Delivery Order contract is for the supply of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a medical product. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of CHLORASEPTIC MAX 15-10 MG LOZ 15S medication. The contract has a ceiling value of $1,224.96 and a period of performance through October 15, 2024. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award, which is a Delivery Order...
This federal contract award is for the procurement of CHLORASEPTIC SORE THROAT LOZENGES by the Defense Logistics Agency (DLA), a defense agency, from the prime contractor Amerisourcebergen Drug Corp. The award has a ceiling value of $1,347.95 and is a Firm Fixed Price delivery order contract that runs through January 9, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8XF
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,449.39, is for the supply of Chloraseptic Max 15-10 mg lozenge products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition. AmerisourceBergen, as the prime contractor, is responsible for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/22/25, 10:06 AM